Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, December 02, 2017 1:55:42 PM
bull flag
inverted head and shoulders bottom
DanDrit Biotech USA, Inc.
U.S. Office
375 Park Avenue, Suite 2607
New York, NY, 10152
United States
Phone: +1 (212) 763 0184
Danish Office
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
Lab Facilities
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark
http://www.dandrit.com
https://mytomorrows.com/en/
DanDrit Biotech USA, Inc. is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit Biotech A/S was founded in 2001 on the research of Professor Jesper Zeuthen at the Danish Cancer Society (Kraeftens Bekaempelse). Dendritic cells are critical components of the immune system. The ability of dendritic cells to induce a strong immune response is the basis of the vaccine therapies under development at DanDrit. Our expertise in producing dendritic cells from a patient’s blood is combined with conventional production methods to make new and advanced vaccines for cancer patients.
The proprietary technology upon which MCV is based is protected by several issued patents.
Also based on a 2011 Nobel Prize for research on dendritic cells.
normal chart
log chart
Recent RENB News
- PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics • GlobeNewswire Inc. • 09/19/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:15:42 PM
- Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection • GlobeNewswire Inc. • 09/17/2024 01:00:00 PM
- RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress • GlobeNewswire Inc. • 09/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 02:30:16 PM
- RenovaroCube Announces Strategic Offering of Up to 20% Ownership • GlobeNewswire Inc. • 09/11/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 08:05:56 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/20/2024 11:53:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:52 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 08/16/2024 08:43:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 09:44:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:32:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 12:46:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 08:50:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 10:38:41 PM
- Renovaro, Inc. Announces $10 million in Equity Committed • GlobeNewswire Inc. • 06/14/2024 01:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/11/2024 03:29:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2024 07:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 01:35:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:33:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 02:19:01 PM
- Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy • GlobeNewswire Inc. • 05/24/2024 01:20:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM